- Home
- STSS vs CXH Comparison
STSS vs CXH Comparison
Compare STSS & CXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STSS | CXH |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 66.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STSS | CXH |
|---|---|---|
| Price | $1.73 | $8.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 446.0K | 10.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $35.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $7.34 |
| 52 Week High | $18.23 | $8.21 |
Technical Indicators
Market Signals| Indicator | STSS | CXH |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 67.37 |
| Support Level | $1.65 | $7.94 |
| Resistance Level | $2.35 | N/A |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 30.65 | 91.84 |
Price Performance
Historical ComparisonAbout STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
About CXH MFS Investment Grade Municipal Trust
Mfs Investment Grade Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowing for investment purposes, in tax-exempt bonds and tax-exempt notes.